News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Deals and strategy
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This article provides a financial overview of Drugs Made In America Acquisition Corp. (DMAAU) as presented on TradingView. It indicates that the market is closed for this stock with no recent trades. The page offers access to financial statements, statistics, dividends, earnings, and segment …
This page provides financial data and an overview for Drugs Made In America Acquisition Corp. (DMAAR) on TradingView. It indicates that the market is closed, with no current trades. Users can find fundamentals, statistics, dividend information, earnings, and segment performance for the company.
This article provides a brief overview of Drugs Made In America Acquisition II Corp. (DMIIU) financial information available on TradingView. It indicates that the market is closed and there are no trades for the company. The page focuses on fundamental data, statements, statistics, dividends, …
This article provides details on the dividend and stock split history for Drugs Made In America Acquisition Corp (DMAA). It notes that no dividends have been distributed over the past five years. The page also displays current stock information, including its price, market cap, …
This article provides a valuation analysis for Drugs Made In America Acquisition Corp (DMAA), focusing on its P/E ratio, P/B ratio, and fair value. As of July 24th, DMAA's stock was trading at $10.709 with a market cap of $361.09 million and a TTM …
This article provides the balance sheet for Drugs Made In America Acquisition Corp (DMAA), detailing its quarterly and annual financial health. It includes key financial metrics such as cash, assets, liabilities, and shareholders' equity, allowing for an analysis of the company's fundamentals and liquidity. …
This article provides an in-depth look at the cash flow statement for Drugs Made In America Acquisition Corp (DMAA), detailing its operating, investing, and financing activities. It presents both annual and quarterly data, highlighting significant changes such as a notable increase in operating cash …
This article provides the income statement for Drugs Made In America Acquisition Corp (DMAA), including quarterly and annual financial data. It details key metrics such as operating expenses, operating profit, net non-operating interest income, income before and after tax, net income, and earnings per …
This article provides a company overview for Drugs Made In America Acquisition Corp (DMAA), including its stock performance and market capitalization. It notes that relevant revenue breakdown data by business segment and region have not yet been disclosed by the company. The page also …
This article provides a detailed financial overview of Drugs Made In America Acquisition Corp (DMAA), a blank check company focused on the pharmaceutical industry. It presents real-time stock quotes, key financial figures, technical indicators, and shareholder information. The company has not yet disclosed relevant …
Search by ticker symbol or company name and select a result to open its chart.